KRTL BioTech

London Stock Exchange in talks to buy Refinitiv for $27 billion

London Stock Exchange in talks to buy Refinitiv for $27 billion

The London Stock Exchange Group Plc said on Friday it was in discussions to acquire financial data analytics provider Refinitiv Holdings Ltd for $27 billion, including debt.